Reliance Industries, through its subsidiary Reliance Strategic Business Ventures (RSBVL), has acquired the oncology-focused healthcare platform Karkinos for Rs 375 crore. The acquisition was completed ...

Last week, Reliance bought oncology platform Karkinos Healthcare for Rs 375 crore, adding another stack to its diagnostic and ...

Billionaire Mukesh Ambani's Reliance Industries has acquired technology-driven and oncology-focused healthcare platform ...

Led by billionaire Mukesh Ambani, India’s largest company by market cap – Reliance Industries (RIL) - on Saturday informed ...

The development follows the approval of a resolution plan for Karkinos Healthcare by NCLT after it entered the Corporate Insolvency Resolution Process (CIRP) in May. Tata Group to invest Rs 110 ...

Reliance Industries Ltd has invested $13 billion in acquisitions over the past five years, shifting focus from oil to clean energy, telecom, retail, a ...

Reliance Industries has acquired Karkinos Healthcare, a technology-driven oncology platform, for Rs 375 crore. Reliance Strategic Business Ventures (RSBVL), a wholly-owned subsidiary of Reliance ...

Karkinos is a giant crab-like creature found on the Ark Valeguero map. These creatures provide a unique in-game utility of picking and carrying animals to a taming pen and are also very useful in ...

As part of its expansion in the healthcare sector, Reliance Industries is also investing Rs202.16 crore in Karkinos Healthcare, a technology-led oncology platform which is underinsolvency process.

Karkinos is a company based in Mumbai, Maharashtra, India, specialising in the healthtech sector. Founded in 2020, it now employs 463 individuals. The company was established by Manish Thakkar ...

Reliance Industries, through its subsidiary RSBVL, has acquired the oncology-focused platform Karkinos for Rs 375 crore. Karkinos provides technology-driven cancer care solutions and aims to offer ...

Last week, Reliance bought oncology platform Karkinos Healthcare for ₹375 crore, adding another stack to its diagnostic and digital healthcare ecosystem, Morgan Stanley said in a report.